IntegraGen is part of the TB-VIR European research network (Collaborative Project) coordinated by the National Center for Scientific Research (CNRS, Dr. Olivier Neyrolles, Toulouse - FRANCE).  This consortium brings together 11 partners, including 3 private companies and 8 laboratories, from 3 Member States of the European Union and 2 Asian countries. It is supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme.
>more

IntegraGen appoints Bernard COURTIEU as CEO in a move to accelerate its commercial effort
read more

Integragen becomes first certified French service provider for Illumina Goldengate and Infinium Genotyping
read more

IntegraGen SA Establishes a US Subsidiary to Commercialize Its Molecular Tests in the USA: Robert Gottlieb Appointed CEO of IntegraGen, Inc.
read more

IntegraGen announces €2 million Equity Investment by DSM Venturing, alongside R&D partnership with DSM Personalized Nutrition Group
read more

Integragen appoints director for new genetic research services
read more

Integragen appoints Jörg Leenings as head of sales and marketing of its German competence center for genetic diabetes testing
read more

IntegraGen, in conjunction with First Signs, Inc. and Boston University School of Medicine, to sponsor CME accredited program at AAP National Conference Satellite Symposia : Autism Spectrum Disorders: Tools to Manage Expectations and Outcomes (AAP National Conference in Boston - Sunday evening - Octobre 12, 2008)
=> more

IntegraGen to exhibit at American Academy of Pediatrics's (AAP) 2008 National Conference in Boston, MA - October 11-14, 2008 - visit us at booth 3772.
> more